Novel and Exceptional Technology and Research Advisory Committee Meeting

The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will hold a virtual meeting to discuss the draft report of the Working Group on Data Science and Emerging Technology.  In addition, the meeting will include a discussion of next steps for the Committee (Federal Register notice).

Registration is not required to view the webcast.

The materials below contain content that is not fully supported by assistive technology. For accessibility assistance with these files, please contact: SciencePolicy@od.nih.gov.

NIH Videocast

https://videocast.nih.gov/watch=52218

Agenda

NExTRAC August 29, 2023 Agenda

Minutes

NIH NExTRAC August 29, 2023 Meeting Minutes

Meeting Materials

Draft Report of the NExTRAC WG on Data Science and Emerging Technology*

*Note: The NExTRAC working group’s report is a draft, pre-decisional document. The NExTRAC publicly discussed and endorsed the draft findings and recommendations with minor modifications to the report at the August 29, 2023 meeting. The final NExTRAC report was transmitted to the Acting NIH Director and can be found here.

Public Comments

Members of the public may request to make an oral public comment or may submit written public comments. To sign up to make an oral public comment, please submit your name, affiliation, and short description of the oral comment to SciencePolicy@od.nih.gov by August 25, 2023. Once all time slots are filled, only written comments will be accepted.

Any interested person may file written comments by e-mailing SciencePolicy@od.nih.gov by August 25, 2023. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Other than name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your comments. Please note that any comments NIH receives may be posted unredacted to the Office of Science Policy website.

Additional Files

Presentation – Draft Report of the Working Group on Data Science and Emerging Technology
Presentation – ENGAGE Charge to the NExTRAC

Novel and Exceptional Technology and Research Advisory Committee

Federal Register Notice

NIH Videocast

The Novel and Exceptional Technology and Research Advisory Committee (NExTRAC) will hold a virtual meeting to hear an update from the Working Group on Data Science and Emerging Technology on its work to address the charge the Committee received in June 2021.

Registration is not required to view the webcast.

Agenda

Minutes

Progress on Phase 1 of Current Charge

Additional Meeting Materials

Public Comments

Novel and Exceptional Technology and Research Advisory Committee

Virtual Meeting

Federal Register Notice

Webcast

Agenda

Minutes

Draft Report of the Gene Drives in Biomedical Research Working Group

*Note: The NExTRAC working group’s report is a draft, pre-decisional document. The NExTRAC publicly discussed and endorsed the draft findings and recommendations with minor modifications to the report at the June 25, 2021, meeting. The final NExTRAC report can be found here.

Additional Meeting Materials

This material contains content that is not fully supported by assistive technology. For accessibility assistance with these files, please contact: SciencePolicy@od.nih.gov.

Public Comments

Novel and Exceptional Technology and Research Advisory Committee

Virtual Meeting

Federal Register Notice

Webcast

Agenda

Meeting

Draft Report of the Working Group to Establish a NExTRAC Framework

  • Draft Report of the Working Group to Establish a NExTRAC Framework
  • The draft report of the Working Group to Establish a NExTRAC Framework was prepared in response to the charge given by the NIH Director at the December 2019 NExTRAC meeting to:
    • “Describe effective approaches for prospectively identifying emerging biotechnologies or specific applications with reasonable potential to have important scientific, safety, or ethical considerations
    • Conceptualize a framework for NExTRAC deliberation of issues surrounding emerging biotechnologies and applications, including:
      • Guiding principles for when an emerging biotechnology or its applications would significantly benefit from further public deliberation
      • A potential process by which the NExTRAC will consider or evaluate any given emerging biotechnology or its applications”

Additional Meeting Materials

Slides

This material contains content that is not fully supported by assistive technology. For accessibility assistance with these files, please contact: SciencePolicy@od.nih.gov.

SESSION I: GENE DRIVES IN BIOMEDICAL RESEARCH

SESSION II: BIOSAFETY GUIDANCE FOR CONTAINED RESEARCH

SESSION III: SCIENCE OF BIOLOGICAL AND ENVIRONMENTAL RISK MITIGATION APPROACHES

SESSION IV: STRATEGIES FOR ASSESSING RISK AND BENEFIT FOR GENE DRIVE FIELD RELEASE

SESSION V: US AND INTERNATIONAL POLICY DISCUSSIONS AND OVERSIGHT FRAMEWORKS FOR RESEARCH INVOLVING GENE DRIVE FIELD RELEASE

SESSION VI: PUBLIC ENGAGEMENT- INPUT FROM LOCAL COMMUNITIES

SESSION VII: STRATEGIES FOR STAKEHOLDER AND PUBLIC ENGAGEMENT

SESSION VIII: DRAFT REPORT OF THE WORKING GROUP TO ESTABLISH A NEXTRAC FRAMEWORK

Public Comments